地址：江苏省无锡市梁溪区锡沪东路8号301-2 电话：0510-82732223 / 86-0510-82732223 邮箱：info@dldevelop.com.cn
备案号：苏ICP备06050612号-1 苏公网安备 32020302000048号 版权所有 @2016 无锡市东林科技发展有限责任公司Language:English
电话:86-0510-82732223
邮箱:info@dldevelop.com.cn
| Product name: | Rabbit anti-p38 (pT180) Antibody |
| Catalog: | DL92187A |
| Synonyms : | CSBP; CSBP1; CSBP2; CSPB1; MXI2; SAPK2A; Mitogen-activated protein kinase 14; MAP kinase 14; MAPK 14; Cytokine suppressive anti-inflammatory drug-binding protein; CSAID-binding protein; CSBP; MAP kinase MXI2; MAX-interacting protein 2; Mitogen-activated protein kinase p38 alpha; MAP kinase p38 alpha; Stress-activated protein kinase 2a; SAPK2a |
| Reactivity: | H, M, R, D, Z |
| Applications: | WB, IF/IC, IP |
| Size: | 50uL/100uL |
| Host: | Rabbit |
| Clonality: | Polyclonal |
| Concentration: | 1mg/mL |
| Immunogen: | KLH-conjugated synthetic peptide encompassing a sequence within the center region of human p38 (pT180). The exact sequence is proprietary. |
| WB description: | Western blot analysis of p38 (pT180) expression in HepG2 PMA-treated (A), NIH3T3 (B), PC12 (C) whole cell lysates. |
| IF/ICC description: | Immunofluorescent analysis of p38 (pT180) staining in HepG2 cells. Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with the primary antibody in 3% BSA-PBS and incubated overnight at 4 ℃ in a humidified chamber. Cells were washed with PBST and incubated with a DyLight 594-conjugated secondary antibody (red) in PBS at room temperature in the dark. |
| Purification_Method: | The antibody was purified by immunogen affinity chromatography. |
| Buffer: | Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% glycerol, and 0.01% sodium azide. |
| Dilution: | WB (1/500 - 1/1000), IF/IC (1/100 - 1/500), IP (1/10 - 1/100) |
| Gene ID(Human): | 1432 |
| Gene ID (Mouse)): | 26416 |
| SwissProt (Human): | Q16539 |
| Storage: | Store at -20℃. Avoid repeated freeze / thaw cycles. |